These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21465129)

  • 21. Anti-factor Xa levels in patients undergoing laparoscopic sleeve gastrectomy: 2 different dosing regimens of enoxaparin.
    Gelikas S; Eldar SM; Lahat G
    Surg Obes Relat Dis; 2017 Oct; 13(10):1753-1759. PubMed ID: 28918992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight-Based Enoxaparin for Venous Thromboembolism in Obesity Gives Similar Anti-Xa Levels to Patients <100 kg, with No Increase in Major Bleeding.
    Maclachlan KH; Stevens HP; Tran HA; Chunilal SD
    Semin Thromb Hemost; 2019 Feb; 45(1):94-99. PubMed ID: 30630208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of suspected pulmonary embolism in a morbidly obese patient.
    Heitlage V; Borgstadt MB; Carlson L
    Am J Health Syst Pharm; 2017 Jul; 74(13):977-980. PubMed ID: 28645996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
    Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
    Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
    Yam L; Bahjri K; Geslani V; Cotton A; Hong L
    Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight-Based Enoxaparin Achieves Adequate Anti-Xa Levels More Often in Trauma Patients: A Prospective Study.
    Stutsrim AE; Eady JM; Collum M; Rebo GJ; Rebo KA; Miller PR; Nunn AM
    Am Surg; 2021 Jan; 87(1):77-82. PubMed ID: 32915054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.
    Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA
    J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients.
    Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R
    J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
    Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
    JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
    Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
    J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients.
    Gibson CM; Hall C; Davis S; Schillig JM
    J Thromb Thrombolysis; 2021 Aug; 52(2):577-583. PubMed ID: 33400099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital.
    Petrie S; Barras M; Lust K; Fagermo N; Allen J; Martin JH
    Intern Med J; 2016 Jul; 46(7):826-33. PubMed ID: 27087147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.
    Miranda S; Le Cam-Duchez V; Benichou J; Donnadieu N; Barbay V; Le Besnerais M; Delmas FX; Cuvelier A; Lévesque H; Benhamou Y; Armengol G
    Thromb Res; 2017 Jul; 155():1-5. PubMed ID: 28460259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity.
    van Oosterom N; Winckel K; Barras M
    J Thromb Thrombolysis; 2019 Oct; 48(3):387-393. PubMed ID: 30945098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-center Experience with Venous Thromboembolism Prophylaxis for Obese Burn Patients.
    McKinzie BP; Nizamani R; Jones S; King B; Williams FN
    J Burn Care Res; 2021 May; 42(3):365-368. PubMed ID: 33674883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism.
    Fan JL; Roberts LE; Scheurer ME; Yee DL; Shah MD; Lee-Kim YJ
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.